Critical infrastructure in biopharma and medical devices plays a vital role in enabling innovation, bolstering research and development, and ensuring the production of novel drugs and products. It ...

Azurity Pharma gets US FDA approval for Danziten tablets, the first and only nilotinib with no mealtime restrictions: Woburn, Massachusetts Saturday, November 16, 2024, 17:00 Hrs ...

Osivax announces first participant vaccinated in phase 2a clinical booster trial of influenza vaccine candidate OVX836: Lyon, France Saturday, November 16, 2024, 14:00 Hrs [IST] O ...

EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

Peethaambaran Kunnathoor, Chennai Saturday, November 16, 2024, 08:00 Hrs [IST] ...

AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...

New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...

LEO Pharma’s Anzupgo cream to treat chronic hand eczema receives marketing approval in Switzerland: Ballerup, Denmark Saturday, November 16, 2024, 15:00 Hrs [IST] LEO Pharma A/S ...

Nandita Vijayasimha, Bengaluru Saturday, November 16, 2024, 08:00 Hrs [IST] ...

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

New technologies and treatments revolutionizing diabetes care: Dr Ajay Aggarwal: Shardul Nautiyal, Mumbai Saturday, November 16, 2024, 08:00 Hrs [IST] As diabetes continues to ris ...

NCCE recommends reports generated by automatic analyser can be signed by technician: Our Bureau, New Delhi Saturday, November 16, 2024, 08:00 Hrs [IST] The National Council for Cl ...